Versant Vantage I, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 17,703 shares at $33.06 ($586K) on 2020-11-09, disclosed to the SEC on 2020-11-10.
Scheduled sale ($586k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.13 | 362 | $12K | 2.0% |
| 2 | $33.13 | 2,738 | $91K | 15.5% |
| 3 | $33.13 | 2,738 | $91K | 15.5% |
| 4 | $33.06 | 735 | $24K | 4.1% |
| 5 | $33.06 | 5,565 | $184K | 31.4% |
| 6 | $33.06 | 5,565 |
| $184K |
| 31.4% |
| Total | $33.08 avg | 17,703 | $586K | 100% |
| Filing → |
| BDTX | SELL | 2020-11-23 | $8.6M | — | Filing → |
| BDTX | SELL | 2020-11-12 | $2.6M | — | Filing → |
| RPTX | BUY | 2020-06-25 | $5.0M | — | Filing → |